Grade 1 Meningioma — Trials

Grade 1 Meningioma — Trials · CancerIndex

Clinical trials

Registered studies

20 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04082520	Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy	recruiting	Phase 2	42	Mayo ClinicOTHER	1	Apr 22, 2026	clinicaltrials
NCT04659811	Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma	active not recruiting	Phase 2	35	Nancy Ann Oberheim Bush, MDOTHER	1	Apr 15, 2026	clinicaltrials
NCT01125046	Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas	completed	Phase 2	50	Northwestern UniversityOTHER	1	Jan 22, 2021	clinicaltrials
NCT00045110	Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma

Data updated 22 days agoSource updated Apr 22, 2026source: clinicaltrials